Gao Jia-Wei, Shi Zhe-Yi, Zhu Zhao-Bi, Xu Xiang-Rong, Chen Wei
Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu Province, China.
Department of General Surgery, Kunshan Hospital Affiliated to Jiangsu University, Suzhou 215300, Jiangsu Province, China.
World J Clin Cases. 2023 Dec 26;11(36):8527-8534. doi: 10.12998/wjcc.v11.i36.8527.
Castleman disease (CD) was first reported in 1954. It is a rare non-malignant lymphoproliferative disease with unclear etiology. As the clinical manifestations of CD are different, there are difficulties in its diagnosis and treatment. Therefore, for patients with CD, it is important to establish the diagnosis in order to choose the appropriate treatment.
In this report, three patients with intraperitoneal CD treated at our center from January 2018 to June 2023 were reviewed, and the clinical and paraclinical examinations, diagnosis, and treatment were analyzed, and all three patients were diagnosed with CD by routine histopathological and immunohistochemical examinations.
CD is a complex and rare disease. Because there are no special clinical symptoms and laboratory abnormalities, the diagnosis often depends on routine pathological and immunohistochemical findings.
卡斯特曼病(CD)于1954年首次被报道。它是一种病因不明的罕见非恶性淋巴增生性疾病。由于CD的临床表现各异,其诊断和治疗存在困难。因此,对于CD患者,明确诊断以选择合适的治疗方法很重要。
本报告回顾了2018年1月至2023年6月在我们中心接受治疗的3例腹腔内CD患者,分析了其临床和辅助检查、诊断及治疗情况,所有3例患者均通过常规组织病理学和免疫组织化学检查确诊为CD。
CD是一种复杂的罕见疾病。由于没有特殊的临床症状和实验室异常,诊断通常依赖于常规病理和免疫组织化学检查结果。